Bronchitol Recommended for Approval by Australian Advisory Committee

13th Dec 10

Release Date: 13/12/2010 12:00am

Pharmaxis today announced that at its recent meeting, the Australian Advisory Committee on Prescription Medicines (ACPM) has recommended approval of Bronchitol (inhaled dry powder mannitol) for marketing in Australia for the treatment of cystic fibrosis.


Read full media release - pdf

Categories: News and Media